Cargando…

Antibodies to SARS-CoV-2 and risk of past or future sick leave

The extent that antibodies to SARS-CoV-2 may protect against future virus-associated disease is unknown. We invited all employees (n = 15,300) at work at the Karolinska University Hospital, Stockholm, Sweden to participate in a study examining SARS-Cov-2 antibodies in relation to registered sick lea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dillner, Joakim, Elfström, K. Miriam, Blomqvist, Jonas, Eklund, Carina, Lagheden, Camilla, Nordqvist-Kleppe, Sara, Hellström, Cecilia, Olofsson, Jennie, Andersson, Eni, Jernbom Falk, August, Bergström, Sofia, Hultin, Emilie, Pin, Elisa, Månberg, Anna, Nilsson, Peter, Hedhammar, My, Hober, Sophia, Mattsson, Johan, Mühr, Laila Sara Arroyo, Conneryd Lundgren, Kalle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933367/ https://www.ncbi.nlm.nih.gov/pubmed/33664279 http://dx.doi.org/10.1038/s41598-021-84356-w

Ejemplares similares

Differences in risk for SARS-CoV-2 infection among healthcare workers
por: Elfström, K. Miriam, et al.
Publicado: (2021)

De novo sequence assembly requires bioinformatic checking of chimeric sequences
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2020)

Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2020)

Predicting past and future SARS-CoV-2-related sick leave using discrete time Markov modelling
por: Lei, Jiayao, et al.
Publicado: (2022)

HPV transcription in skin tumors
por: Hultin, Emilie, et al.
Publicado: (2019)

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer
por: Lagheden, Camilla, et al.
Publicado: (2018)

High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study
por: Lei, Jiayao, et al.
Publicado: (2018)

Viruses in case series of tumors: Consistent presence in different cancers in the same subject
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2017)

Cervical screening and risk of adenosquamous and rare histological types of invasive cervical carcinoma: population based nested case-control study
por: Andrae, Bengt, et al.
Publicado: (2019)

Human papillomavirus type 16 genomic variation in women with subsequent in situ or invasive cervical cancer: prospective population-based study
por: Arroyo-Mühr, Laila Sara, et al.
Publicado: (2018)

Potential SARS-CoV-2 infectiousness among asymptomatic healthcare workers
por: Pimenoff, Ville N., et al.
Publicado: (2021)

Deep sequencing extends the diversity of human papillomaviruses in human skin
por: Bzhalava, Davit, et al.
Publicado: (2014)

Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs
por: Vänskä, Simopekka, et al.
Publicado: (2020)

Risk for SARS-CoV-2 infection in healthcare workers outside hospitals: A real-life immuno-virological study during the first wave of the COVID-19 epidemic
por: Fröberg, Maria, et al.
Publicado: (2021)

Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
por: Rudberg, Ann-Sofie, et al.
Publicado: (2020)

Systematic evaluation of SARS‐CoV‐2 antigens enables a highly specific and sensitive multiplex serological COVID‐19 assay
por: Hober, Sophia, et al.
Publicado: (2021)

Risk of SARS-CoV-2 exposure among hospital healthcare workers in relation to patient contact and type of care
por: Klevebro, Susanna, et al.
Publicado: (2021)

Cervical cancer case–control audit: Results from routine evaluation of a nationwide cervical screening program
por: Wang, Jiangrong, et al.
Publicado: (2019)

Impact of cervical screening by human papillomavirus genotype: Population-based estimations
por: Wang, Jiangrong, et al.
Publicado: (2023)

Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody Responses( )
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
por: Havervall, Sebastian, et al.
Publicado: (2022)

Detection of DNA viruses in prostate cancer
por: Smelov, Vitaly, et al.
Publicado: (2016)

Corrigendum: Detection of DNA viruses in prostate cancer
por: Smelov, Vitaly, et al.
Publicado: (2016)

Comparison of DNA and RNA sequencing of total nucleic acids from human cervix for metagenomics
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2021)

Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19
por: Havervall, Sebastian, et al.
Publicado: (2021)

Assessment of bacterial and viral gut communities in healthy and tumoral colorectal tissue using RNA and DNA deep sequencing
por: Garcia‐Serrano, Ainhoa, et al.
Publicado: (2023)

A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodies
por: Mravinacova, Sara, et al.
Publicado: (2022)

Metatranscriptome analysis in human papillomavirus negative cervical cancers
por: Ure, Agustin Enrique, et al.
Publicado: (2022)

Extension of the viral ecology in humans using viral profile hidden Markov models
por: Bzhalava, Zurab, et al.
Publicado: (2018)

A pilot study of risk-stratified cervical cancer screening
por: Wang, Jiangrong, et al.
Publicado: (2022)

Organized primary human papillomavirus–based cervical screening: A randomized healthcare policy trial
por: Elfström, K. Miriam, et al.
Publicado: (2021)

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial
por: Elfström, K Miriam, et al.
Publicado: (2014)

Randomised healthcare policy evaluation of organised primary human papillomavirus screening of women aged 56–60
por: Lamin, Helena, et al.
Publicado: (2017)

Negative-Pressure Wound Therapy Versus Standard Treatment of Adult Patients With Conflict-Related Extremity Wounds: Protocol for a Randomized Controlled Trial
por: Älgå, Andreas, et al.
Publicado: (2018)

Estimating total excess mortality during a COVID-19 outbreak in Stockholm, Sweden
por: Pimenoff, Ville N, et al.
Publicado: (2020)

Improved Surgical Outcome with Double Incision and Free Nipple Graft in Gender Confirmation Mastectomy
por: Kamali, Alexander, et al.
Publicado: (2021)

Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type
por: Persson, Maria, et al.
Publicado: (2015)

Autoantibody profiles associated with clinical features in psychotic disorders
por: Jernbom Falk, August, et al.
Publicado: (2021)

Cervical cancer screening in Sweden 2014-2016
por: Hortlund, Maria, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i1eokqj93ukai14ffn571hkkda